Curcumin blocks cyclosporine A-resistant CD28 costimulatory pathway of human T-cell proliferation

Journal of Surgical Research

Volumn 77, Issue 2, 1998, Pages 174-178

  Ranjan, Dinesh ^a   Johnston, Thomas D ^a   Wu, Guanghan ^a   Elliott, Lucinda ^b   Bondada, Subbarao ^b   Nagabhushan, M ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; CD28; Curcumin; Immunosuppression

Indexed keywords

CD28 ANTIGEN; CURCUMIN; CYCLOSPORIN A;

APOPTOSIS; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0032124324     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5374     Document Type: Article

References (26)

1. Alberola-Ila J., Satoshi Takaki S., Kerner J. D., Perlmutter R. M. Differential signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 15:1997;125.
2. Cantrell, C. T cell antigen receptor signal transduction pathways, Annu. Rev. Immunol. 14, 259.
3. Lin H., Wei R., Goodman R. E., Bolling S. F. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation. Thorac. Surg. Cardiol. 122:1997;129.
4. Linsley P. S., Ledbetter J. A. The role of the CD28 receptor during t cell responses to antigen. Annu. Rev. Immunol. 11:1993;191.
5. Ohnishi H., Ledbetter J. A., Kanner S. B., Linsley P. S., Tanaka T., Geller A. M., Kotb M. CD28 cross-linking augments TCR-mediated signals and costimulates superantigen responses. J. Immunol. 154:1995;3180.
6. Turcovski-Corrales S. M., Fenton R. G., Peltz G., Taub D. D. CD28:B7 interactions promote T cell adhesion. Eur. J. Immunol. 25:1995;3087.
7. Masy E., Labalette-Houache M., Dessaint J. P. Individual susceptibility to cyclosporine: Possible involvement of the CD28/CD80 (B7/BB1) pathway. Transplant. Proc. 26:1994;2846.
8. Atluru S., Atluru D. Evidence that genistein, a protein-tyrosine kinase inhibitor, inhibits CD28 monoclonal-antibody-stimulated human t cell proliferation. Transplantation. 51:1991;448.
9. Ammon H. P. T., Safayhi H., Mack T., Sabieraj J. Mechanism of antiinflammatory actions of curcumin and boswellic acids. J. Ethnopharm. 38:1993;113.
10. Ruby A. J., Kuttan G., Babu K. D., Rajasekharan K. N., Kuttan R. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett. 94:1995;79.
11. Mukundan M. A., Chacko M. C., Annapurna V. V., Krishnaswamy K. Effect of turmeric and curcumin on bp-dna adducts. Carcinogenesis. 14:1993;493.
12. Jiang M. C., Yang-Yen H. F., Yen J. J., Lin J. K. Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr. Cancer. 26:1996;111.
13. Liu J., Lin S., Lin J. Inhibitory effects of curcumin on protein kinase c activity induced by 12-0-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis. 14:1993;857.
14. Muthukkumar S., Han S., Mutukkumar S., Rangnekar V. M., Bondada S. Role of egr-1 gene expression in B cell receptor-induced apoptosis in an immature B cell lymphoma. J. Biol. Chem. 272:1997;27987.
15. Reid S., Cross R., Snow C. Combined Hoechst 33342 and merocyanine 540 staining to examine murine B cell cycle stage, viability and apoptosis. J. Immunol. Methods. 192:1996;43.
16. Cantrell D. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14:1996;259.
17. Van Gool S. W., Ceuppens J. L., Walter H., de Boer M. Synergy between cyclosporin A and a monoclonal antibody to B7 in blocking alloantigen-induced T-cell activation. Blood. 83:1994;176.
18. Siefken R., Kurrle R., Schwinzer R. CD28-mediated activation of resting human t cells without costimulation of the CD3/TCR complex. Cell. Immunol. 176:1997;59.
19. Luy G., Bjorndahl J. M., Phillips C. A., Trevillyanjm. CD28 induced T cell activation evidence of for a PTK signal transduction pathway. J. Immunol. 149:1992;24.
20. van Lier R. A. W., Brouwer M., De Groot E., Dramere I., Aarden L. A., Verhoeven A. J. T cell receptor/CD3 and CD28 use distinct intracellular signaling pathways. Eur. J. Immunol. 21:1991;1775.
21. Nadeau K., Azuma H., Chandraker A., Sayegh M. H., Tilney N. L. Inhibition of CD28-B7 T-cell costimulatory activation pathway affects intragraft cytokine and growth factor expression in chronic renal allograft rejection. Transplant. Proc. 29:1997;1038.
22. Lenschow D. J., Walunas T. L., Bluestone J. A. CD28/B7 system of T-cell costimulation. Annu. Rev. Immunol. 14:1996;233.
23. Boise L. H., Minn A. J., Noel P. J., June C. H., Accavitti M., Lindstein T., Thompson B. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity. 3:1995;87.
24. Ranjan, D. Siquijor, A. Johnston, T. D. Wu, G. Nagabhuskahn, M. The effect of curcumin on human B-cell immortalization by Epstein-Barr virus, Am. Surgeon.
25. Singh S., Aggarwal B. B. Activation of transcription factor NF-KB is suppressed by curcumin (diferulolylmethane). J. Biol. Chem. 270:1995;24995.
26. Mehta K., Pantazis P., McQueen T., Aggarwal B. B. Antiproliferative effect of curcumin against human breast tumor cell lines. Anticancer Drugs. 8:1997;470.